Literature DB >> 19260252

Inflammatory myofibroblastic tumor of the small intestine: a case report of a 2 month-old infant.

Phisek Yimyaem1, Surachai Saranrittichai, Poonsiri Sinawat, Tula Dhiensiri.   

Abstract

Benign intestinal tumors are rare in children; however, the authors describe an inflammatory myofibroblastic tumor (IMT) of the terminal ileum in a 2-month-old infant who presented with an intestinal obstruction. During laparotomy, an annular mass around the terminal ileum was resected, from which a histological diagnosis of IMT was made. A review of the literature for this rare condition was done to delineate the natural history of this tumor and to do a histological confirmation of its benign nature. Because of the risk of local recurrence, IMT cases should have a long-term follow up.

Entities:  

Mesh:

Year:  2009        PMID: 19260252

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  Abdominal inflammatory myofibroblastic tumor: report on four cases and review of literature.

Authors:  Alireza Mirshemirani; Ahmad Khaleghnejad Tabari; Naser Sadeghian; Siamak Shariat-Torbaghan; Marina Pourafkari; Leila Mohajerzadeh
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

2.  Inflammatory myofibroblastic bladder tumor in a patient with wolf-hirschhorn syndrome.

Authors:  Antonio Marte; Paolo Indolfi; Carmine Ficociello; Daniela Russo; Matilde Oreste; Gaetano Bottigliero; Giovanna Gualdiero; Ciro Barone; Elena Vigliar; Cristiana Indolfi; Fiorina Casale
Journal:  Case Rep Urol       Date:  2013-08-18

3.  Inflammatory myofibroblastic tumor of the small intestine: A case report.

Authors:  Abdolhamid Amouei; Fatemeh Ehsani; Marzie Vaghefi; Seyed Mostafa Tabatabai; Pouria Yazdian Anari
Journal:  Int J Surg Case Rep       Date:  2016-03-24

4.  Inflammatory myofibroblastic tumor: A rare cause of invagination in adults.

Authors:  Remzi Kiziltan; Ozkan Yilmaz; Necat Almali; Caghan Peksen
Journal:  Pak J Med Sci       Date:  2016 Jan-Feb       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.